LBO — WEST ANAHEIM MEDICAL CENTER
IRR: 16.6% | MOIC: 2.16x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
16.6%
IRR
2.16x
MOIC
$177.7M
Entry EV
$267.8M
Exit EV
$91.4M
Equity Invested
Sources & Uses
S&UTotal · $177.7M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $69.0M | 38.8% | |
| Sub Debt | $17.2M | 9.7% | |
| Equity | $91.4M | 51.5% | |
| Enterprise Value | $172.5M | 97.1% | |
| Transaction Fees | $5.2M | 2.9% | |
| Total Uses | $177.7M | 100.0% |
Interpretation
INTAt 2.16x MOIC and 16.6% IRR over 5 years, this deal meets the 15-20% range — acceptable with operational upside.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $25.5M |
| Exit Ev | $267.8M |
| Net Debt At Exit | $70.6M |
| Equity At Exit | $197.2M |
| Equity Invested | $91.4M |
| Total Value Created | $105.8M |
| Value From Growth | $86.7M |
| Value From Multiple | $8.6M |
| Value From Deleveraging | $15.6M |